Andy Kaempf
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Lymphatic System and Diseases
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 25
- Acute Myeloid Leukemia Research 18
- Chronic Myeloid Leukemia Treatments 13
-
- Advanced Breast Cancer Therapies 8
- Co-authors
- Motomi Mori (9 shared papers)Zahi Mitri (7 shared papers)Young Hwan Chang (1 shared paper)Amanda W. Lund (1 shared paper)Christopher P. Loo (1 shared paper)Jeffrey Tyner (18 shared papers)Guillaume Thibault (1 shared paper)Takahiro Tsujikawa (1 shared paper)
- Journals
- Blood (21 papers)Journal of Clinical Oncology (3 papers)Leukemia (3 papers)BMC Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- United StatesIndiaPhilippines
In The Last Decade
Andy Kaempf
45 papers receiving 563 citations
Peers
Comparison fields: 5 of 62
- Hematology 123
- Oncology 194
- Immunology 136
- Genetics 62
- Pulmonary and Respiratory Medicine 114
Countries citing papers authored by Andy Kaempf
This map shows the geographic impact of Andy Kaempf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Kaempf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Kaempf more than expected).
Fields of papers citing papers by Andy Kaempf
This network shows the impact of papers produced by Andy Kaempf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Kaempf. The network helps show where Andy Kaempf may publish in the future.
Co-authors
The 25 scholars most cited alongside Andy Kaempf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 133 | |
| 2 | 2018 | 87 | |
| 3 | 2018 | 52 | |
| 4 | 2021 | 39 | |
| 5 | 2020 | 38 | |
| 6 | 2022 | 24 | |
| 7 | 2021 | 23 | |
| 8 | 2021 | 20 | |
| 9 | 2020 | 16 | |
| 10 | 2018 | 15 | |
| 11 | 2023 | 13 | |
| 12 | 2013 | 11 | |
| 13 | 2023 | 10 | |
| 14 | 2018 | 9 | |
| 15 | 2022 | 8 | |
| 16 | 2018 | 8 | |
| 17 | 2023 | 6 | |
| 18 | 2018 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2023 | 5 |
About Andy Kaempf
Andy Kaempf is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Oncology, having authored 54 papers that have together received 566 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Advanced Breast Cancer Therapies (8 papers), Acute Lymphoblastic Leukemia research (6 papers), Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Hematology (123 citations), Oncology (194 citations), Immunology (136 citations), Genetics (62 citations) and Pulmonary and Respiratory Medicine (114 citations). Andy Kaempf has collaborated with scholars based in United States, India and Philippines. Frequent co-authors include Motomi Mori, Zahi Mitri, Young Hwan Chang, Amanda W. Lund, Christopher P. Loo, Jeffrey Tyner, Guillaume Thibault, Takahiro Tsujikawa, Julia Femel and Ryan S. Lane. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, BMC Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.